Kathrin Schirner

Global Safety Lead
CSL Behring Innovation GmbH, Marburg, Germany
Marburg, Hessen, Germany

Presentation(s):

• PB1245 - Efficacy, safety and dosing of pasteurized plasma-derived von Willebrand factor/Factor VIII concentrate for the treatment of von Willebrand Disease: a systematic review

  Tuesday, June 27, 2023
  18:30 – 19:30 ET